Specialist labs in France and Sweden have confirmed Russian opposition leader Alexei Navalny was poisoned with the Soviet-era nerve agent Novichok, the German government said Monday.
A German military laboratory previously confirmed the substance in his samples. German government spokesman Steffen Seibert said that the Hague-based Organization for the Prohibition of Chemical Weapons has also received samples and is taking steps to have those tested at its reference laboratories.
"Independently of the ongoing examinations by the OPCW, three laboratories have now confirmed independently of one another the proof of a nerve agent of the Novichok group as the cause of Mr. Navalny's poisoning, Seibert said in a statement.
He said Germany had asked France and Sweden for an independent review of the German findings using new samples from Navalny.
Navalny, the most visible opponent of Russian President Vladimir Putin, was flown to Germany two days after falling ill on August 20 on a domestic flight in Russia. Berlin has demanded that Russia investigate the case.
Seibert on Monday renewed Germany's demand that Russia explain itself on the matter.
He added that we are in close consultation with our European partners on further steps.
The Kremlin has bristled at calls from Chancellor Angela Merkel and other world leaders for Russia to answer questions in the case, denying any official involvement and accusing the West of trying to smear Moscow.
Russian authorities have prodded Germany to share the evidence that led it to conclude without doubt that Navalny was poisoned with a military nerve agent from the Novichok group, the same class of Soviet-era agent that British authorities said was used on former Russian spy Sergei Skripal and his daughter in Salisbury, England, in 2018.
Berlin has rejected suggestions from Moscow that it is dragging its heels.
Navalny was kept in an induced coma for more than a week as he was treated with an antidote, before hospital officials said a week ago that his condition had improved enough for him to be brought out of it.
It isn't clear when Berlin's Charite hospital will next issue an update on his condition.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)